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CASE REPORT
INTRODUCTION
Dengue Fever (DF) is an acute mosquito-
transmitted disease caused by the dengue fever virus
of the family Flaviviridae, the most common cause of
arboviral disease in the world. Clinical manifestations
of dengue infection range from fever, headache,
arthralgia, myalgia and skin rash, to severe hemorrhage,
shock, and death.1 It is estimated that there are
100 million cases of dengue infection, 500,000 cases
of dengue hemorrhagic fever and 25,000 deaths due to
dengue annually worldwide.1
In South East Asia, Dengue Hemorrhagic Fever
(DHF) has been recognized for approximately 40 years.
The vast majority of the cases are reported from
Thailand, Indonesia, and Vietnam, which have very
comprehensive surveillance systems. Per decade,
the number of DHF cases has increased-from a mean
of 50,000 per year in the 1970s to 165,000 in the 1980s
and 200,000 in the 1990s.2
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ABSTRACT
Dengue fever is an acute mosquito-transmitted disease caused by the dengue fever virus which had
clinical manifestations range from fever to severe hemorrhage, shock, and death.1 There were
500,000 cases of dengue hemorrhagic fever and 25,000 deaths due to dengue annually worldwide.
Bleeding is one of the major problems encountered in dengue fever. The reported prevalence of upper
gastrointestinal bleeding in dengue patients varies from 5% to 30%. The pathogenesis of
hemorrhage could be multifactor and include vasculopathy, platelet deficiency, and dysfunction, and
blood coagulation defects. We presented here a case of 27 years-old male patient who had clinical
manifestation of hematemesis on his third day of fever.
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Bleeding, one of the major problems encountered
in DF, contributes to a worsening morbidity. The toxic
hemorrhagic state appears during the third to fifth day
of the illness, following the onset of fever, followed by
convalescent stage. The most common hemorrhagic
manifestations are epistaxis, skin hemorrhages, and
gastrointestinal hemorrhages.1
The reported prevalence of upper gastrointestinal
bleeding in dengue patients varies from 5% to 30%.
Wang JY et al, found 11.8% of DF patient developed
gastrointestinal hemorrhage with manifestation of
haematemesis and/or melena.3 Yi-Chun et al,
identified 97 (8.4%) among 1,156 dengue patients had
complications of upper gastrointestinal (GI) bleeding
during hospitalization.3 The endoscopic findings
included hemorrhagic (and/or erosive) gastritis in 67%
of the patients, gastric ulcer in 57.7%, duodenal ulcer
in 26.8% and esophageal ulcer in 3.1.1
Most of the dengue patient who developed upper
gastrointestinal bleeding had gastric ulcer or duodenal
ulcers; superficial and hemorrhagic gastritis are other
relevant endoscopic findings. Fifty percent patients had
past history of peptic ulcers symptoms, whereas
the other 50% were not. Dengue infection is
a precipitating factor in inducing peptic ulcer bleeding
because of hemostatic derangements.4
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The pathogenesis of hemorrhage could be
multifactor and include vasculopathy, platelet deficiency,
and dysfunction, and blood coagulation defects. Most
upper GI bleeding occurs on the fourth day after
the onset of fever. In addition, almost all of dengue
patients recovered after 7-14 days. Close monitoring
of vital signs and hematocryte to evaluate the severity
hemorrhage is mandatory to reduce morbidity.
However, this acute disease will soon subside, and
platelet count and function will spontaneously return to
normal.1
However, the pathogenic mechanism of dengue
virus (DV)-induced hemorrhage awaits clarification.
A recent research “Both virus and tumor necrosis
factor alpha are critical for endothelium damage in
a mouse model of dengue virus-induced hemorrhage”
reveals that high viral titer, macrophage infiltration, and
tumor necrosis factor alpha (TNF-α) production in
the local tissues are three important events that lead to
hemorrhage.5
In this report, a 27 years-old male patient presented
with hematemesis on his third day of fever. Further
examination confirm positive serum dengue antibody.
This is a case demonstration to illustrate feature of GI
tract bleeding in DHF patient.
CASE ILLUSTRATION
A 27 years old male, had twice hematemesis just
an hour prior admission. The amount of blood was about
one cup (200 cc). Preceded by nausea and epigastric
pain, the emesis were bright red, mixed with the food
he just ate. He had sudden onset of fever 3 days
before admission, relieved by antipyretic. He was
taking paracetamol and amoxicillin. He also complained
of headache, joint and muscular pain. There was
melena but no previous bloody hematemesis, epistaxis,
nor bleeding gums. He admitted taking Indonesian
traditional herbs called jamu beras merah two glasses
a day for two days, and admitted drink alcohol 2 years
ago, but had stopped for two years. There was no
previous history of gastritis nor jaundice. His sister was
recently hospitalized for DHF.
His physical examination revealed moderate illness,
compos mentis, blood pressure 110/80 mmHg, heart
rate 120 beat/minutes, respiration rate 20 times/
minutes, and fever, temperature 38.4oC.
The tourniquet test was positive.
Unless epigastric pain, other physical condition was
unremarkable. Specifically no rash, conjunctiva
injection, stigmata of neither cirrhosis nor jaundice was
noted. Rectal examination was performing and reveals
a mass at anal mucosa. It was supple and aches and
no black stool was found. Laboratory findings were
hemoglobin 13.8 g/dL, hematocryte 39%, leukocytes
7,200/µL, platelet count 153,000/uL, leukocyte
differential count 0/1/2/81/15/1, blood sedimentation rate
10 mm/hour, urea 19 mg/dL, creatinin 1.4 mg/dL, total
protein 6.7 g/dL, albumin 4.5 g/dL, globulin 2.2 g/dL,
random balance sugar 127, sodium 133 meq/L,
potassium 3.4 meq/L, and chloride 98 meq/L.
Urinalysis were normal. Patient’s chest X-ray was
clear. Based on these data, we conclude the problems
were hematemesis melena, DHF grade 1, electrolyte
disturbances and internal hemorrhoid.
The patient was not allowed to take food or drinks
and Nasogastric Tube (NGT) was placed. The liquid
from showed bright, red blood or blood clots. Then,
NGT was gently lavaged with room temperature
water every six hour. Intravenous access was obtained,
with infusion of crystalloid. Proton pump inhibitor,
sistenol, sucralfat, and ondansentron were
administered.
About 24 hours later the NGT came out clear and
the patient started enteral nutrition. The patient was
then planned for the evaluation for the cause of
hematemesis by upper GI tract endoscopy.
The Complete Blood Count (CBC) was checked
every 12 hours and close monitoring of vital sign was
obtained. On second day of hospitalization, patient
complaint passaging of bright red blood from
the rectum not intermixed with formed stool. The CBC
were hemoglobin 15.8 g/dL, hematocryte 43.8%,
leukocytes 2,100/ µL and platelet count 64,000/µL,
prothrombin time 15.2 second (C:12.2), activated
prothrombin time 44.2 second (C: 30.1), bleeding time
2 second, clotting time 11 second, fibrinogen 122 and
D-dimer 700. IgG and IgM anti dengue were both
negative. On day 5, the patient had no longer fever,
and the CBC were hemoglobin 16.1 g/dL, hematocryt
45.1%, leukocytes 4,000/µL and platelet count
18,000/µL. IgG anti dengue was positive at day 7
(day 10 of illness). The upper GI endoscopy was
performed on May 14th showed esophagitis and mild
erosive gastritis. The pathology anatomy results came
out on May 21st revealed a non-atrophic chronic
gastritis and no Helicobacter pylori was found.
DISCUSSION
Hematemesis in this patient was thought to be due
to erosive gastritis cause by the traditional herbs
he had been taking. In a retrospective study about
the causes of upper gastrointestinal bleeding in Cipto
Mangunkusumo hospital, the cause of upper
gastrointestinal bleeding was non variceal (66.5%) and
variceal (33.5%). Among non variceal, ulcer and
erosive gastritis was most frequent cause.6
Laboratory findings when patient first admitted were
the platelet count 153,000/µL and hematocryte 39%.
Patient was given ringer lactate/4 hours. Hematocryte
after 4-hours fluid replacement was
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decrease to 38%. There was also thrombocytopenia
134,000/µL, and leukopenia 4,800/µL.
The positive tourniquet test along with
thrombocytopenia, leukopenia, and recent fever
confirm dengue hemorrhagic fever as the diagnosis.
WHO definition for dengue hemorrhagic fever are as
follows:7 (1) Current or recent fever; (2) Platelet count
< 100,000/ ìL (3) Hemorrhagic manifestation;
(4) Objective evidence of plasma leakage caused by
increased vascular permeability manifested by at least
one of the following: elevated hematocryte (< 20% over
baseline or a similar drop after intravenous
replacement); pleural effusion (e.g. ascites); low
protein.
Positive tourniquet confirms DF. However, level of
thrombocyte at the time of hematemesis was in
normal range 153,000/µL. An early diagnosis of DHF
is difficult because the WHO clinical and laboratory
criteria for DHF may be manifested only in the late
phase of acute illness.8 As in the next day of
hospitalization, clinically and laboratorial, patient develop
more obvious DF manifestation. Thrombocytes level
was lower and patient no longer fever. IgG anti
dengue was positive at day 7 (day 10 of illness).
When GI bleeding is suspected, rapid assessment
of the patient is carried out to monitor and determine
whether the bleeding acute or chronic? Is the patient
hemodynamically stable or unstable?. It is helpful to
confirm the presence of GI bleeding with inspection of
the stool or nasogastric aspirate, but the first goal is to
stabilize the patient. Vital signs are recorded,
the patient’s skin and mucous membranes are inspected
for pallor or a sign of shock, and blood is sent to
the laboratory for complete blood count, routine
chemistries, and clotting studies. Blood for typing and
cross matching is sent to the blood bank so that
transfusions can be given without delay if needed.9
The presence of GI bleeding in this patient was
confirmed by both inspection of the stool and
nasogastric aspirate. During admitted, patient’s was
hemodynamically stable.
The hematocryte does not fall immediately with
hemorrhage because of proportionate reductions of
plasma and red cell volumes (i.e. “people bleed whole
blood”). Hence, during this time, the severity of
bleeding must not be underestimated because of
a normal or only minimally decreased hematocryte.
As extra vascular fluid enters the vascular space to
restore volume, the hematocryte falls. This process,
which begins shortly after the onset of bleeding, is not
complete for 24 to 72 hours, by which time the total
vascular volume has been restored. At this point, plasma
volume is larger than normal and the hematocryte is
at its lowest point. This sequence is modified by
pre-existing abnormalities in vascular volume or by
administration of exogenous fluids and blood.9
Patient’s hematocryte was 39% (N: 40-48), and
4 hours later 38%. This minimally decrease hematocryte
along with subside symptoms of bleeding and stability
of patient’s hemodynamic status, should not be
interpreted as a definite indication of recurrent
bleeding. The rapid intravenous replacement of fluid
and electrolytes using normal saline can often sustain
patients until they have a spontaneous recovery.
Colloid preparations, such as dextran 70, should be
given if the pulse pressure is 10 mmHg or less or
the hematocryte remains elevated after fluid
replacement.10
On second day of hospitalization, patient complaint
passaging of bright red blood from the rectum.
The laboratory work-up reveals a more pronounced
DHF symptom. The increase of hemoglobin and
hematocryte (hemoglobin 15.8 g/dL, hematocryte
43.8%), leukopenia 2,100/µL and thrombocytopenia
64,000/µL.
The diagnosis was grade 2 dengue hemorrhagic
fever with hemorrhoid and history of hematemesis.
The management was close monitoring on vital signs
and administration of fluids.
Nausea and epigastric pain before vomiting and
history of herbs he had been taking and alcohol
consumption suggested an erosive gastritis as
the cause. Other possible diagnosis to be considered
was esophageal varices or Mallory Weiss tear. An upper
gastrointestinal endoscopy then scheduled to confirm
the diagnosis.
Sudden onset of three-day fever with constitutional
symptom such as headache, joint and muscular pain
with positive tourniquet test due to dengue fever.
Classic dengue fever is characterized by the sudden
onset of fever and a variety of non specific signs and
symptoms, including frontal headache, retro-orbital pain,
body aches, nausea, vomiting, joint pains, weakness,
and rash.11,12
Upper gastrointestinal bleeding occurred in
a median of 4 days (range 1-9) after the onset of fever
in DHF patient while the most severe thrombo-
cytopenia was reported on day 4-5 after the onset of
fever.1 In this patient the hematemesis appear on day
three of febrile, and the lowest platelet count was on
day 8.
Raquel et al, revealed that DHF patients had a lower
thrombocytes count, had more hemorrhagic
manifestation and gastrointestinal manifestation than
dengue fever patient. The critical stage of the disease
is reached at the end of febrile phase. It is at this time
that thrombocytopenia is pronounced which may lead
to bleeding.13
The pathogenesis of abnormal hemostasis in DHF
includes vasculopathy (from anaphylotoxin released by
complement activation), thrombopathy (decreased
platelet production increase destruction), and
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coagulopathy, including prothrombin complex deficiency
due to liver damaged and consumptive coagulopathy.14
This patient was likely to develop the secondary
dengue viral infection. IgG was positive at day 10, while
IgM was negative. There should have been
a re-evaluation of patient’s IgM to confirm
a secondary newly infection.
Dengue blot had a sensitivity of 25.9% in detecting
primary infection and 100% in detecting secondary
infections hence this is suitable for use in areas where
majority of cases are secondary infection.11
Three to four days following primary infection, IgM
appeared and gradually increase to the peak level, then
decrease to disappear in 30-60 days. The raise titer of
IgM followed by IgG, which increase to the peak level
within 15 days and decrease gradually that it stays in
small titer for life. In secondary infection, IgM has
already disappeared and IgG stays in a small titer.
Newly infected by dengue virus for the second time,
IgG will be produced in high titer rapidly while IgM
followed.13
In secondary infections, antibodies are largely of
the IgG class and are directed against the antigens of
the flavivirus group on the dengue virus complex or
subcomplex.14
The risk of DHF is higher in patients experiencing
a second dengue infection, DHF also occurs in
patients who have primary infections, which suggests
that heterogonous dengue antibody (previous infection)
is not a prerequisite for DHF. Furthermore, some strains
of dengue viruses cannot be enhanced in vitro. Both
field evidence and laboratory evidence support a more
prominent role of viral factors in the pathogenesis of
DHF and suggest that virus strain and serotype are
also important risk factors for severe disease.
Hemorrhage may occur without vascular leakage,
suggesting another pathogenetic mechanism.15
The endoscopic findings of this patient were mild
erosive gastritis. It is consistent with Chiu YC et al.
who found hemorrhagic (and/or) erosive gastritis as
the most common findings among dengue patients with
gastrointestinal bleeding.1 Tsai CJ et al, found gastric
ulcers or duodenal ulcers; superficial and hemorrhagic
gastritis as endoscopic feature of DHF patients, and
50% patients had history of peptic ulcer and other 50%
were not. So, both DF patient with or without history
of peptic ulcer symptom can develop gastrointestinal
bleeding.4
Patient did admit consumed traditional herbs 2 days
before admission and there was a history of
alcoholism. The medicine he had been taking during
early days of fever also contributes to erosive
gastritis. It was confirmed by endoscopic findings, mild
erosive gastritis. Patient presented with hematemesis
melena because of erosive gastritis, and DHF
contributes to it.
Pathology anatomy examination reveals a non-
atrophic chronic gastritis. It is probably due to
the alcohol that the patient had consumed two years
ago.
Evidence of intestinal mucosal injury in patients with
dengue infection was demonstrated in a study
determine whether there is an association between
dengue infection and intestinal mucosal injury. Serum
levels of intestinal fatty acid binding protein (I-FABP)
were used as a specific marker for mucosal injury.
The patients with DHF grade IV had the highest
levels of serum I-FABP, ALT, and AST compared to
the other groups. However, there were no differences
in serum I-FABP, ALT, and AST levels among patients
with DF, DHF grade I, grade II, and grade III.
Patients with DHF grade IV had high serum I-FABP
levels and had associated liver injury.16
Perng DS et al, concluded that: 58.5% of
the dengue fever patient disclosed hemorrhagic
gastritis in their endoscopic findings. Patients with
platelet count < 50,000/µL suffered from upper GI
bleeding at a detection rate of around 48.6%. On the
other hand, the detection rate was around 29.7% in
those patients with platelet count over 50,000/µL. Thus
a significant difference was shown (p < 0.025).
The platelet count decreased significantly in patients
who had had oral medication before endoscopy
compared to those without oral medication.
The detection rate of upper GI bleeding was 40.6%
and 26% respectively (p < 0.025). Most upper GI
bleeding cases occurred after the 4th day of onset. There
was no significant relationship between upper GI
bleeding and symptoms of epigastralgia or cutaneous
eruption. In cases of presenting hemorrhagic gastritis
and superficial plus hemorrhagic gastritis by endoscopy,
the detection rate of upper GI bleeding seemed higher
but there was no statistical difference.17
DF is an acute disease that may induce severe
hemorrhage by multifactor pathogenesis. Mucosal
injury, vaculopathy, platelet deficiencies and
dysfunction, and blood coagulation defects are some
of the proposed mechanism. Erosive gastritis was
the most common endoscopy findings in DHF patient.
Patient in this case developed chronic gastritis, which
became erosive once he suffered from dengue fever.
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